Frequencies of <i>HLA-C</i> C1 and C2 gene groups in different diseases.
- Izabela Nowak (307694)
- Edyta Majorczyk (307703)
- Andrzej Wiśniewski (307701)
- Andrzej Pawlik (307709)
- Maria Magott-Procelewska (307695)
- Ewa Passowicz-Muszyńska (362139)
- Jacek Malejczyk (362140)
- Rafał Płoski (85995)
- Sebastian Giebel (362141)
- Ewa Barcz (307710)
- Aleksandra Zoń-Giebel (362142)
- Andrzej Malinowski (362143)
- Henryk Tchórzewski (362144)
- Arkadiusz Chlebicki (362145)
- Wioleta Łuszczek (307707)
- Maciej Kurpisz (362146)
- Marian Gryboś (362147)
- Jacek Wilczyński (362148)
- Piotr Wiland (362149)
- David Senitzer (307711)
- Ji-Yao Sun (362150)
- Renata Jankowska (362151)
- Marian Klinger (307705)
- Piotr Kuśnierczyk (307712)
Publication date
February 2013
DOIAbstract
<p>AS, ankylosing spondylitis; RA, rheumatoid arthritis; E, endometriosis; KGR, kidney graft rejectors; KGRN, kidney graft non-rejectors; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CML, chronic myeloid leukemia; NSCLC, non-small cell lung carcinoma; Control I, healthy volunteers; Control II, healthy fertile women; *compared to Control I; **compared to Control II.</p>a<p><i>p</i> = 0.02 <i>OR</i> = 0.55 <i>95%CI</i> 0.35–0.88.</p>b<p><i>p</i> = 0.02 <i>OR</i> = 1.81 <i>95%CI</i> 1.14–2.89.</p>c<p><i>p</i> = 0.006 <i>OR</i> = 0.67 <i>95%CI</i> 0.50–0.89.</p
Add to ORKG